Innocan Pharma Corporation (OTCMKTS:INNPF) Stock In Focus After Expansion News

News about fresh sales and expansion to new territories could always come as significant news for many investors. Hence, it may be the right time to consider taking a look into the Innocan Pharma Corporation (OTCMKTS:INNPF) stock over the coming days.

Trading Data

On Monday, INNPF stock ended flat at $0.1430 with more than 3.60K shares, compared to volume of 392 shares. The stock moved within a range of $0.1430 – 0.1430 after opening trade at $0.1430.

Innocan Pharma Announces 5000 Units Sale and Expansion to Lithuania, Latvia & Estonia Markets

 The company announced yesterday that it had gone into a commercial distribution agreement with a wide scope with UAB Medexy. It is a distribution agreement of several years and as part of its, UAB would also have the sole rights to distribute the Innocan brands SHIR and RELIEF&GO in Latvia, Estonia and Lithiuania markets.

As it happens, UAB already placed the first order under the distribution agreement and it was for more than 5000 units of SHIR and RELIEF&GO products. In this regard, it ought to be noted that UAB Medexy has managed to build up a reputation as a major player in the import and distribution of cosmetic products in the Eastern European market.

It has been an active player in the dermo-cosmetics space in Lithuania for the past 17 years and emerged as one of the most important players in that industry. The CBD skin care market is projected to hit a valuation of $10376.4 million by 2028.